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Abstract
Background: Our previous study demonstrated that nitric oxide (NO) contributes to long-term potentiation (LTP)
of C-fiber-evoked field potentials by tetanic stimulation of the sciatic nerve in the spinal cord in vivo. Ryanodine
receptor (RyR) is a downstream target for NO. The present study further explored the role of RyR in synaptic
plasticity of the spinal pain pathway.
Results: By means of field potential recordings in the adult male rat in vivo, we showed that RyR antagonist
reduced LTP of C-fiber-evoked responses in the spinal dorsal horn by tetanic stimulation of the sciatic nerve. Using
spinal cord slice preparations and field potential recordings from superficial dorsal horn, high frequency stimulation
of Lissauer’s tract (LT) stably induced LTP of field excitatory postsynaptic potentials (fEPSPs). Perfusion of RyR
antagonists blocked the induction of LT stimulation-evoked spinal LTP, while Ins(1,4,5)P3 receptor (IP3R) antagonist
had no significant effect on LTP induction. Moreover, activation of RyRs by caffeine without high frequency
stimulation induced a long-term potentiation in the presence of bicuculline methiodide and strychnine. Further, in
patch-clamp recordings from superficial dorsal horn neurons, activation of RyRs resulted in a large increase in the
frequency of miniature EPSCs (mEPSCs). Immunohistochemical study showed that RyRs were expressed in the
dorsal root ganglion (DRG) neurons. Likewise, calcium imaging in small DRG neurons illustrated that activation of
RyRs elevated [Ca
2+]i in small DRG neurons.
Conclusions: These data indicate that activation of presynaptic RyRs play a crucial role in the induction of LTP in
the spinal pain pathway, probably through enhancement of transmitter release.
Background
LTP is a long-lasting form of synaptic plasticity in many
parts of the central nervous system, particularly in the
hippocampus [1]. Likewise, compelling evidence reveals
that tetanic stimulation of the peripheral nerve produces
LTP of C-fiber-evoked responses in the spinal dorsal
horn both in vivo [2-5] and in vitro [6,7], and prolonged
behavioral pain hypersensitivity [8]. Therefore, it is con-
ceivable that C-afferent-induced spinal LTP may be a
substrate for central sensitization of the pain pathway,
which amplifies nociceptive input resulting in hyperalge-
sia [4].
Nitric oxide (NO) is a diffusible messenger throughout
the central nervous system. Considerable evidence
implicates the formation of NO in mechanisms underly-
ing hyperalgesia and allodynia [9-11]. Likewise, NO con-
tributes to spinal LTP of C-fiber-evoked field potentials
[12-14]. This gas may diffuse retrogradely from postsy-
naptic neurons of the spinal dorsal horn, enhancing the
release of pain-associated transmitters. It is, therefore,
speculated that the presynaptic action of NO may con-
tribute to the induction of spinal LTP [12,13]. To our
knowledge, there is no direct morphological and physio-
logical evidence to identify the action of NO on noci-
ceptive primary afferent terminals in the spinal cord.
It is known that the ryanodine receptor (RyR) is a
down-stream target for NO [15]. The RyR and the Ins
(1,4,5)P3 receptor (IP3R) in intracellular calcium stores
constitute a fundamental calcium source. Ca
2+ released
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ter release from presynaptic terminals of central
synapses [16,17].
Using spinal cord slice preparations and field potential
and patch-clamp recordings from superficial dorsal horn
neurons, field potential recordings in the spinal dorsal
horn in vivo, immunohistochemistry and calcium ima-
ging in DRG neurons, the present study was to address
a possible role of ryanodine receptors in the induction
of spinal LTP.
Results
LTP of fEPSPs by stimulation of Lissauer’s tract (LT) in the
spinal cord slice
Field potentials in the spinal dorsal horn (DH) were
induced by stimulation of the LT (0.1 ms, 0.7-1 mA, 5-
min interval) via a bipolar tungsten electrode. After per-
fusion with bicuculline methiodide (10 μM) and strych-
nine (1 μM) for 1 h, field excitatory postsynaptic
potentials (fEPSPs) recorded stably for 10 min served as
control. Following high-frequency stimulation (HFS, 100
Hz for 1 sec, three times at 10-sec intervals), fEPSPs
were significantly enhanced to 132.4 ± 3.1% of control
(P <0 . 0 0 1 ,F i g .1 A )a t3 0m i na f t e rH F Si na l l2 4
recorded cases, indicating creation of spinal LTP. The
LTP of fEPSPs stably lasted for more than 3 h (173.9 ±
11.4% of control, n = 8, P < 0.001) (Fig. 1B).
Involvement of RyR, but not IP3R, in the induction of
spinal LTP
It is reported that low (2 μM) and high (20 μM) concen-
trations of ryanodine function as agonist and antagonist
of RyRs in the hippocampus, respectively [18]. Perfusion
with 20 μM ryanodine 1 h before conditioning HFS
failed to enhance fEPSPs (102.1 ± 1.6% of control, n =
8; Fig. 1C). Similarly, dantrolene (10 μM), another
antagonist for RyR, also did not evoke significant poten-
tiation of fEPSPs (104.0 ± 3.8% of control, n = 7; Fig.
1D) without the effect on the baseline of fEPSPs (Fig.
1E). With washout of dantrolene, spinal LTP returned
(119.0 ± 3.1% of control, n = 3; Fig. 1D). These results
indicated blockade of the induction of LTP by RyR
antagonists. It is reasonable to conclude that RyRs are
involved in the induction of LTP of fEPSPs. However,
When dantrolene was sustainedly delivered 30 min after
conditioning HFS, the established LTP was not blocked
(164.1 ± 5.6% of control, n = 6; Fig. 1F), suggesting that
R y R sa r eu n l i k e l yt oc o n t r i b u t et ot h em a i n t e n a n c eo f
spinal LTP.
To further confirm the involvement of RyR in the
induction of LTP in the spinal pain pathway, we then
performed electrophysiological recordings in vivo.C o n -
sistent with our previous study [3], C-fiber-evoked field
potentials in the spinal dorsal horn were induced by
electrical test stimulation of the sciatic nerve (0.5 ms,
15-20 V, 1-min intervals) in anesthetized rats. When
tetanic stimulation (0.5 ms, 100 Hz, 30-40 V, 10 trains
of 2-sec duration at 10-sec intervals) was applied to the
sciatic nerve 30 min after intrathecal injection of vehicle
(0.25% DMSO, 10 μl), LTP of C-fiber-evoked field
potentials was induced (P <0 . 0 0 1 ,c o m p a r e dw i t ht h e
baseline responses of 30 min before intrathecal injection
of vehicle). The field potentials were increased to 174.46
± 8.66% of control at 1 h after tetanic stimulation.
When ryanodine (1 mM, 10 μl) was intrathecally applied
30 min before tetanic stimulation, the induction of
spinal LTP was prevented (P < 0.001, compared with
vehicle, Fig. 2).
The RyR is a downstream target of NO [15]. Perfusion
with 50 μM L-NAME, a NO synthase (NOS) inhibitor, 1
h before conditioning HFS of LT inhibited the induction
of LTP (Fig. 3). If the RyR as a NO target was activated,
L-NAME-induced inhibition of spinal LTP might be
reversed and in turn LTP could occur. As expected,
when 5 μM cyclic ADP-ribose (cADPR), an endogenous
agonist of the RyR, was perfused 10 min before L-
NAME, LTP re-appeared (Fig. 3).
We detected possible effect of another calcium store
receptor IP3Ro ns p i n a lL T P .W h e n7 5μM2 - A P B ,a n
IP3 receptor antagonist, was perfused 1 h before HFS,
there was no significant effect on the induction of LTP
(126.4 ± 4.2% of control, n = 8; Fig. 4A). Moreover, sus-
tained perfusion with 2-APB (75 μM) 1 h before condi-
tioning HFS of LT and for the whole period of
recording failed to alter the established LTP (Fig. 4A)
(158.3 ± 8.9% of control, n = 4). To exclude whether
the negative result may be attributable to the low effi-
cacy of 2-APB, we further assessed its effect in hippo-
campal slices. The amplitude of fEPSPs were increased
to 154.1 ± 21.2% of control at 30 min after conditioning
HFS (n = 4). Perfusion with 75 μM 2-APB 1 h prior to
HFS completely blocked the induction of hippocampal
LTP (67.4 ± 10.2% of control, 30 min after HFS; n = 5)
(Fig. 4B). This result provides additional evidence for
the lack of involvement of IP3 receptors in both the
induction and maintenance of spinal LTP.
RyRs agonist alone is sufficient for inducing LTP of fEPSPs
in spinal cord slice
Field potentials were evoked by stimulation of the dorsal
root (DR) in the spinal cord slice with an attached dor-
sal root. Caffeine at 10 mM, RyR agonist, can activate
Ca
2+-induced Ca
2+ release by increasing the affinity for
Ca
2+ of the RyRs [19]. To address whether activation of
RyRs is sufficient for induction of spinal LTP, we tested
the effect of 10 mM caffeine on DR stimulation-induced
fEPSPs in the presence of 10 μM bicuculline and 1 μM
strychnine. Perfusion with 10 mM caffeine alone for 2
min without conditioning HFS produced LTP of fEPSPs
lasting for more than 80 min, during which the
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Page 2 of 11Figure 1 Involvement of RyR in the induction of LTP of fEPSPs in the spinal dorsal horn in vitro. A, fEPSPs were recorded in the presence
of 10 μM bicuculline methiodide and 1 μM strychnine. fEPSPs recorded 10 min before HFS served as control. After HFS, fEPSPs significantly
increased (n = 24). The inserted traces were the original recordings (without averaging). a-b corresponds to the time points as indicated. B, The
LTP of fEPSPs stably lasted for 3 h (n = 8). C,2 0μM ryanodine applied 1 h before HFS blocked the induction of LTP (P < 0.001) (control n = 7;
ryanodine n = 8). The inserted traces were the original recordings. D,1 0μM dantrolene perfused 1 h before HFS blocked the induction of LTP (P
< 0.001) (control n = 7; dantrolene n = 7), and this effect was reversible (P < 0.001) (washout n = 3). E, 10 mM dantrolene has no significant
effect on the amplitude of fEPSP. Control: the amplitude of fEPSP recorded 5 min before dantrolene application (10 μM); Dantrolene: 30 min
after perfusion of dantrolene. Inserts show original traces recorded 5 min before and 30 min after dantrolene. F,1 0μM dantrolene perfused 30
min after HFS had no significant effect on the established LTP (P = 1) (control n = 5; dantrolene n = 6). Data were shown as mean ± s.e.m. in all
figures; n: the number of slices.
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trol (n = 13, Fig. 5A). Notably, the potentiation was
greater after caffeine washout for about 30 min. When
20 μM ryanodine was perfused for 1 h before caffeine
challenge to inactivate RyRs, the enhancement of fEPSPs
was completely blocked (92.4 ± 2.2% of control, n = 5;
Fig. 5B), verifying that RyRs mediate the long-term
potentiation.
Activation of RyRs increases [Ca
2+]i in DRG neurons and
frequency of mEPSCs in superficial dorsal horn neurons
RyRs in the intracellular Ca
2+ store have three isoforms:
RyR1, RyR2 and RyR3 in the nervous system. As shown
in Fig.6, RyR1 and RyR3, but not RyR2, were expressed
in DRG neurons. Moreover, RyR1 and RyR3 were co-
localized with calcitonin gene-related peptide, (CGRP,
marker for peptidergic afferent terminals) and isolectin
B4, (IB4, marker for non-peptidergic afferent terminals),
respectively.
Given RyRs expressed by DRG, the direct action of RyRs
agonists was examined by means of calcium imaging in
the acute isolated small DRG neurons (15-30 μm). A puff
of 10 mM caffeine for 1 or 2 sec increased [Ca
2+]i in 9
DRG neurons tested (Fig. 7A). As mentioned above, low
and high concentration of ryanodine functions respectively
as agonist and antagonist of RyRs. Perfusion of ryanodine
at high concentration (40 μM) 1 h before recording
blocked caffeine-increased [Ca
2+]i (Fig. 7C) and a puff of
Figure 2 Involvement of RyR in the induction of LTP of fEPSPs
in the spinal dorsal horn in vivo. The spinal LTP was blocked by
high concentration of ryanodine (1 mM, 10 μl) intrathecally applied
30 min before tetanic stimulation (P < 0.001, vs. vehicle) (control n
= 5; ryanodine n = 6) in the spinal cord in vivo. Representative
original recordings (average of six consecutive traces) were shown
below from the time points as indicated.
Figure 3 Reversal of L-NAMA-induced inhibition of LTP of fEPSP by cADPR, an endogenous agonist of the RyR. Perfusion with 50 μML -
NAME for 1 h before HFS of LT inhibited the induction of LTP (P < 0.001), which was reversed by co-application of L-NAME and 5 μM cADPR
for 1 h before HFS (P < 0.001) (control, n = 5; L-NAME, n = 6; L-NAME + cADPR, n = 5).
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Page 4 of 11ryanodine at low concentration (2 μM) reversibly elevated
[Ca
2+]i (Fig. 7B), unequivocally supporting that DRG neu-
rons express functional RyRs.
Conventionally, the variation of mEPSC frequency
reflects the probability of presynaptic transmitter release.
In whole-cell patch clamp recording, the effect of caf-
feine on mEPSC was tested in the superficial laminae of
the spinal cord slice with an attached dorsal root. Only
those superficial dorsal horn neurons with monosynaptic
C-fiber input were selected for recording mEPSCs in the
presence of 0.5 μM TTX. Out of total 16 neurons
tested, bath application of 10 mM caffeine significantly
increased the frequency of mEPSCs in 14 neurons (con-
trol: 1.97 ± 0.52 Hz vs caffeine: 4.50 ± 1.14 Hz) (n = 16,
P = 0.0044, Fig. 8A-C), suggesting enhancement of
transmitter release probability. But, there was no signifi-
cant change in the amplitudes of mEPSCs (control:
14.81 ± 1.48 pA vs caffeine: 15.49 ± 1.30 pA) (n = 16, P
= 0.3185, Fig. 8D).
Figure 4 No effect of IP3R antagonist on induction of spinal
LTP in vitro. A,I P 3R antagonist 2-APB (75 μM) applied for 1 h
before HFS of LT had no significant effect either on the induction of
LTP of fEPSPs (P = 0.303) (control, n = 7; 2-APB, 45 min from
baseline, n = 8), or on the established LTP of fEPSPs (P = 0.173)
(control, n = 4; 2-APB, 135 min from baseline, n = 4). B,A sa
positive control, 2-APB blocked the induction of hippocampal LTP.
In the hippocampal slice, 75 μM 2-APB perfused for 1 h before
conditioning stimulation (100 Hz for 1 sec, 3 times at 10-sec
intervals, mimicking spinal HFS) blocked the induction of
hippocampal LTP (control, 30 min after induction of hippocampal
LTP in the presence of 10 μM bicuculline methiodide, n = 4; 2-APB,
30 min after induction of hippocampal LTP in the presence of 10
μM bicuculline methiodide and 75 μM 2-APB, n = 5). Error bars
represent s.e.m. n: the number of slices. **P < 0.01.
Figure 5 Caffeine-induced LTP of fEPSPs in spinal cord slice. A,
After perfusion with 10 mM caffeine for 2 min instantly following
washed out, LTP of fEPSPs occurred without conditioning
stimulation in the presence of 10 μM bicuculline methiodide and 1
μM strychnine, which lasted for more than 80 min. Inserts show
original recordings 5 min before (1) and about 80 min after (2) 10
mM caffeine challenge. Traces were not averaged (n = 13). B,
Perfusion with 20 μM ryanodine 1 hour before caffeine challenge
blocked the induction of LTP of fEPSPs. Inserts show original
recordings without averaging (n = 5).
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The main findings in the present study are as following:
1, Pharmacological blockade of RyRs prevented the
induction of LTP of fEPSPs i nt h es p i n a ld o r s a lh o r n
and RyRs agonist alone induced a long-term potentia-
tion; 2, RyRs were expressed in DRG neurons and acti-
vation of RyRs elevated [Ca
2+]i in small DRG neurons;
3, Activation of RyRs resulted in a large increase in the
frequency of mEPSCs, suggesting a robust increase of
presynaptic transmitter release.
These results provided further evidence for the invol-
vement of RyRs in induction of LTP in the spinal pain
pathway. Sandkuhler group found that RyR antagonist
dantrolene fully blocked low frequency stimulation
(LFS)-induced LTP and opioid withdrawal induced-LTP
in vivo [20,21]. Similarly, the present study showed that
RyR antagonist blocked high frequency stimulation
(HFS)-induced LTP in the in vitro test and titanic sciatic
stimulation-induced LTP in the in vivo test. It is possi-
ble that three different kinds of spinal long-term synap-
tic plasticity by HFS, LFS and opioid withdrawal may
share a similar mechanism of presynaptic activation of
RyRs. However, inconsistent with the previous study
[22], we detected no significant contribution of IP3Rf o r
HFS-induced LTP in the spinal dorsal horn in vitro (Fig.
4). In support to this, a similar result was obtained in
LTP of field potential recordings in vivo (data not
shown). In their study, blockade of IP3Rc o n v e r t e dL F S -
induced LTP into LTD in lamina I spino-PAG neurons,
which is similar to our positive control in the hippocam-
pal slices (Fig. 4B). In addition to the different experi-
mental conditions, the contradictory results might be
attributed to an involvement of IP3Ro n l yi nL F S -
induced LTP in lamina I spino-PAG neurons but not
traditional HFS-induced LTP.
The cellular mechanisms underlying RyR-mediated
spinal LTP are poorly understood. Our and other evi-
dences suggest that two signal molecules, NO and gluta-
mate, may play a crucial role in RyR function for spinal
LTP. Firstly, Previous studies have verified that tetanic
stimulation produces a sustained increase in the
amounts of glutamate and aspartate from primary C-
fiber terminals in the spinal cord [7,23,24] and that
blockade of NMDA receptors or the glutamate transpor-
ter GLT-1 inhibited the spinal induction of LTP, sug-
gesting a crucial role of glutamate [5]. As shown in Fig.
8A-C, activation of RyRs largely increases in the fre-
quency of mEPSCs in the superficial DH neurons,
further supporting enhancement of presynaptic release
of transmitters such as glutamate.
Synaptic inputs to the recording dorsal horn neurons
mainly derive from two sources: 1) Interneurons of the
spinal dorsal horn; 2) Primary afferent terminals.
Although we do not further locate the expression of
RyRs, and the action of spinal interneurons can not
exclude, but combined with the calcium imaging results
Figure 6 Expression of ryanodine receptors 1 or 3 (RyR1, RyR3) and their co- localization with IB4 or CGRP in DRG neurons in normal
rats. A, Co-localization of RyR1 (red) with IB4 (green) in DRG neurons. B, Co-localization of RyR3 (red) and CGRP (green) in DRG neurons, scale:
50 μm.
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2+]i in DRG neurons
and RyRs expression by DRG neurons, it is reasonable
to speculate that activation of RyRs expressed by presy-
naptic primary sensory neurons may at least partially
involved in the enhancement of glutamate release. Sec-
ondly, consistent with hippocampcal LTP [25,26], the
diffusible messenger NO also contributes to the induc-
tion of spinal LTP [13,14]. It is well documented that
NMDA receptor activation induces NO synthesis from
arginine [9]. Furthermore, peripheral noxious stimuli or
intrathecal glutamate and NMDA induce NO release in
the dorsal horn in vivo [27]. Intrathecal administration
of NMDA causes an increase in cGMP, a production of
NO target guanylate cyclase (sGC), in the spinal dorsal
horn [28]. Importantly, the RyR is a down-stream target
for the NO-PKG-cADPR signaling pathway and PKG-
induced production of cADPR synergistically with intra-
cellular Ca
2+ activates RyRs [29]. The present result that
pre-perfusion of cADPR, an endogenous agonist of the
RyR, reversed NOS inhibitor-induced inhibition of spinal
Figure 7 Increase in [Ca
2+]i by caffeine in isolated DRG neurons. A, Brief puff of 10 mM caffeine for 1 or 2 s increased [Ca
2+]i transients in
DRG neurons (n = 9). B, Puff of 2 μM ryanodine increased [Ca
2+]i transients (n = 9). C, Adding a high concentration of ryanodine (40 μM) to the
extracellular solution blocked caffeine-induced increase in [Ca
2+]i transients (n = 6). The cell color imaging (a-i) in the right side corresponded to
the time points indicated (a-i) in the left side.
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Page 7 of 11LTP of fEPSPs (Fig. 3), supported that activation of
RyRs by NO is one of the essential factors for induction
of spinal LTP.
Taken together, it is conceivable that glutamate
released from presynaptic terminals by conditioning sti-
mulation activates NMDA receptors in the pain-sensi-
tive neurons in the dorsal horn, and then triggers NO
synthesis in neurons and glia in the spinal cord. NO ret-
rogradely diffuses from postsynaptic spinal pain-sensitive
neurons and glia into presynaptic terminals and acti-
vates RyRs releasing Ca
2+, finally strengthens release of
transmitters. Similarly, the putative process also occurs
in the hippocampus [30,31].
Although our results emphasized presynaptic action of
RyRs in spinal LTP, the postsynaptic function of RyRs is
unable to exclude completely due to our limination of
methodology. Further more work need to be done.
Conclusion
Activation of presynptic RyRs were involved in the
induction of spinal LTP, probably through enhancement
of presynaptic release of neurotransmitters. It is likely
that RyR in primary afferent t e r m i n a l si san o v e lt a r g e t
for treating pain.
Materials and methods
Sprague-Dawley rats were from Experimental Animal
Center, Shanghai Medical College of Fudan University,
China. All procedures of the experiments were approved
by the Committee of Animal Use for Research and Edu-
cation of Fudan University, and all efforts were made to
minimize the number of animals used and their suffer-
ing, in accordance with the ethical guidelines for animal
research [32].
Preparation of spinal cord slices
Young Sprague-Dawley rats (postnatal days 14-21) were
deeply anesthetized with diethyl ether, and for LTP
recording, about 1 ml lidocaine (5 ml:0.1 g) was injected
to both sides of lumbar vertebrae (L4-5). Laminectomy
was performed from mid-thoracic to low lumbar levels
and the cord was quickly removed to cold modified arti-
ficial cerebrospinal fluid (ACSF): (in mM) NaCl, 80;
KCl, 2.5; NaH2PO4, 1.25; CaCl2,0 . 5 ;M g C l 2,3 . 5 ;
NaHCO3, 25; sucrose, 75; ascorbate, 1.3; sodium
Figure 8 Increase in mEPSCs frequency by caffeine in superficial dorsal horn neurons. A, Sample traces of mESPCs recorded from a lamina
II neuron in the presence of 0.5 μM TTX before (left) and after bath application of 10 mM caffeine for about 5 min (right). B. A histogram shows
the time course of changes in mEPSCs frequency before, after and following washout of 10 mM caffeine in the presence of 0.5 μM TTX in an
individual neuron. C and D, The averaged frequency and amplitude for all cells treated with 10 mM caffeine (n = 16; 5 s bins) in the presence of
0.5 μM TTX. Membrane potential was clamped at -70 mV. Error bars represent s.e.m. n: the number of cells.
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Page 8 of 11pyruvate, 3.0; oxygenated with 95% O2 and 5% CO2;p H
7.4; measured osmolarity 310.5 mOsm. Transverse 500
μm slices, with attached dorsal roots, were obtained.
Slices were then incubated for at least 1 h at 35°C in a
solution that consisted of: (in mM) NaCl, 125; KCl, 2.5;
CaCl2, 2; MgCl2, 1, NaH2PO4, 1.25; NaHCO3, 26; D-glu-
cose, 25; ascorbate, 1.3; sodium pyruvate, 3.0; oxyge-
nated with 95% O2 and 5% CO2,p H7 . 4 ;m e a s u r e d
osmolarity 324.5 mOsm. The slice was then transferred
into a recording chamber and perfused with oxygenated
recording solution at a rate of 5 ml min
-1 prior to elec-
trophysiological recordings at room temperature.
Field potential and whole-cell patch clamp recordings
from spinal cord slices
Field potential recordings from the superficial spinal
dorsal horn were performed with glass microelectrodes
(impedance 2-5 MΩ) filled with (in mM) NaCl 135, KCl
5.4, CaCl2 1.8, MgCl2 1, HEPES 5 (pH adjusted to 7.2
with NaOH). A bipolar tungsten electrode was used to
stimulate LT. Low-pass filter was set to 1 kHz, amplifi-
cation 500× (Axopatch 200B, Axon Instruments). To
minimize current spread to the dorsal roots and the
recording site, the electrode was placed at the most ven-
trolateral border of LT [33]. For LTP associated experi-
ments, recordings of fEPSPs were made in the presence
of bicuculline (10 μM) and strychnine (1 μM) to block
tonic inhibitory action of GABAA and glycine receptors
and data are normalized (to mean values of 10 min
before HFS or caffeine exposure) mean peak fEPSPs
amplitudes. In some of the experiments (caffeine asso-
ciated), a suction electrode (A-M systems) was used for
electrical stimulation of the attached dorsal root. Neu-
rons were identified by infrared differential interference
contrast (IR-DIC) video microscopy with an upright
microscope (Leica DMLFSA, Germany) equipped with a
40×, 0.80 NA water-immersion objective and a CCD
camera (IR-1000E, USA). Patch pipettes (5-10 MΩ)
from borosilicate glass were made on a horizontal
micropipette puller (P-97, Sutter Instruments, Novato,
CA, USA) and were filled with (in mM) potassium glu-
conate 120, KCl 20, MgCl2 2, Na2ATP 2, NaGTP 0.5,
HEPES 20, EGTA 0.5, pH 7.28 with KOH, measured
osmolarity 300 mM. To measure EPSCs from neurons
in the inner part of lamina II, the dorsal root was stimu-
lated via a suction electrode. Test pulses of 0.1 msec
(0.7-1 mA) were given at 30 sec intervals. Data were
acquired using an Axopatch 200B patch-clamp amplifier.
Responses were low-pass filtered on-line at 2 kHz, digi-
t i z e da t5k H z ,a n da n a l y z e do f f - l i n eu s i n gC l a m p f i t8 . 1
software. Membrane potential was held at -70 mV and
all recordings were performed at room temperature.
Field potential recording from hippocampal slices
Young Sprague-Dawley rats (postnatal days 14-21) were
deeply anesthetized with diethyl ether. The brain was
quickly removed and immersed in ice-cold ACSF
bubbled with a gas mixture of 95% O2 and 5% CO2. 400
μM transverse slices were prepared. The slices were
then incubated in a chamber maintained at 35°C for at
least 1.5 h before recording, and a single slice was then
transferred into a recording chamber and perfused with
oxygenated recording solution at 3 ml min
-1 prior to
electrophysiological recordings at room temperature.
The composition of the ACSF was (in mM): 124 NaCl,
4.4 KCl, 2.5 CaCl2,1 . 3M g S O 4,1N a H 2PO4,2 6
NaHCO3, and 10 glucose. Field potential recordings
were performed as previously described [15]. Briefly,
fEPSPs were recorded with a glass micropipette contain-
ing 1 M NaCl in the stratum radiatum of the CA1
region, stimulated via a bipolar tungsten electrode
placed along the Schaffer collateral fibers. The stimula-
tion intensity was adjusted to produce a half-maximal
field potential amplitude at the beginning of each
experiment. Test pulses of 0.1 msec were given at 100
s e ci n t e r v a l s .T oi n d u c eL T P ,H F S( 1 0 0H zf o r1s e c ,3
times at 10-sec intervals) was delivered, similar to the
induction protocol for spinal LTP in vitro.
Recording of C-fiber-evoked field potentials in vivo
As we described previously [14], experiments were per-
formed on adult male Sprague-Dawley rats weighing 250-
300 g. Pairs of rats were housed in plastic cages and main-
tained on a 12:12 h light-dark cycle and constant room
temperature of 21°C with free access to food and water.
Urethane (1.5 g/kg, intraperitoneally) was used to induce
and maintain anesthesia. Surgical level of anesthesia was
verified by the absence of corneal reflexes and foot with-
drawal to pinch. The trachea was cannulated to allow
mechanical ventilation with room air, if necessary. One
carotid artery was cannulated to monitor mean arterial
blood pressure, which ranged from 80 to 100 mmHg. A
laminectomy was performed at vertebrae T13-L1 to expose
the lumbar enlargement, and the left sciatic nerve was dis-
sected free for bipolar electrical stimulation with a pair of
stainless-steel hook electrodes. The exposed nervous tis-
sues were covered with warm paraffin oil. An intrathecal
catheter (PE-10 tube) was inserted through the gap
between the L4 and L5 vertebrae and extended to the sub-
arachniod space of the lumbar enlargement (L4 and L5
segments). Colorectal temperature was kept constant at
37-38°C by a feedback-controlled heating blanket. The
electrocardiogram was monitored continuously.
Following electrical stimulation of the sciatic nerve,
the field potentials were recorded in the ipsilateral L4-5
segments, 300-800 μm from the surface of the cord with
glass microelectrodes (impedance 3-6 MΩ)w h i c hw e r e
driven by an electronically controlled microstepping
motor (Narishige Scientific Instrument Co.). The low-
pass filter was adjusted to 100 Hz. An A/D converter
card (SUMP-PC, Shanghai Medical College, Fudan
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10 kHz. A single rectangular pulse (0.5 ms, 15-20 V),
sufficient to excite C afferent fibers, was applied to scia-
tic nerve at 1 min intervals as test stimulus. It was easy
to distinguish the C-fiber-evoked field potentials from
A-fiber-evoked potentials by the latencies of the A and
C responses. After recording stable responses for more
than 40 min, conditioning tetanic stimuli (0.5 m, 100
Hz, 30-40 V, 10 trains of 2 sec duration at 10 sec inter-
vals) were delivered to the sciatic nerve for inducing
LTP of C-fiber-evoked field potentials. The distance
from the stimulation site to the recording site was
approximately 10 cm. At the end of experiments, rats
were killed by an overdose of urethane.
The area of C-fiber-evoked field potentials was deter-
mined off-line by Average Soft provided by the Depart-
ment of Physiology, Shanghai Medical College, Fudan
University. In each experiment, responses to six conse-
cutive test stimuli were averaged. Data are normalized
to mean values of the first 30 min areas of C-fiber
evoked field potentials.
Calcium imaging
As we previously described [34], acutely isolated DRG
neurons were loaded with 1 μM Fura-2 acetoxymethyl
ester (Fura-2/AM; DoJinDo Laboratories, Kumamoto,
Japan). The neurons were observed on an inverted
microscope (Olympus IX51) with a 40× UV flour oil-
immersion objective lens. The fluorescence in individual
neurons was recorded by a cooled CCD camera (Hama-
matsu, Hamamatsu City, Japan), with a 1 Hz alternating
wavelength time scanning with excitation wavelengths of
340 and 380 nm and an emission wavelength of 510 nm
(monochromators; Till Polychrome IV, Munich, Ger-
many). Images were captured every 3 sec. Digitized
images were acquired and analyzed in a personal com-
puter controlled by SimplePCI (Compix, Lake Oswego,
OR). The ratio of the fluorescence at the two excitation
wavelengths was used to estimate changes of [Ca
2+]i.
Immunohistochemistry
Normal adult rats were given an overdose of urethane (2
g/kg, i.p.) and perfused intracardially with 0.9% sterile
saline followed by 4% paraformaldehyde in 0.1 M phos-
p h a t eb u f f e r( P B ,p H7 . 4 ) .T h eL 4-6 DRG were then
removed, post-fixed in the same fixative for 2 h at 4°C,
and immersed in 20% sucrose in PB for 24 h at 4°C for
cryoprotection. Transverse DRG sections (14 μm) were
cut in a cryostat and processed for immunofluorescence.
All sections were blocked with 10% donkey serum in
0.01 M PBS, pH 7.4 with 0.3% Triton-X-100 for 2 h at
room temperature (RT) and incubated 24 h at 4°C with
rabbit anti-RyR 1 and 3 antibody (1: 1000, Chemicon,
Temecula, CA) or a mixture of rabbit anti-RyR 1 and 3
antibody (1: 1000, Chemicon, Temecula, CA) and goat
anti-CGRP antibody (1:500, Santa Cruze) in PBS with
1% normal donkey serum and 0.3% Triton-X-100. Fol-
lowing six 10 min rinses in 0.01 M PBS, the sections
were incubated in a mixture of FITC-conjugated Isolec-
tin B4 (IB4) (1:1000, Sigma) and rhodamine red-X-con-
jugated donkey anti-rabbit IgG (1:100, Jackson
ImmunoResearch, West Grove, PA) for 2 h at 37°C, or
FITC-conjugated donkey anti-goat IgG (1:100, Jackson
ImmunoResearch, West Grove, PA) and rhodamine red-
X-conjugated donkey anti-rabbit IgG (1:100, Jackson
ImmunoResearch, West Grove, PA) for 120 min at RT,
and then washed in PBS. The specificity of immunos-
taining was verified by omitting the primary antibodies,
and immunostaining signal disappeared after omitting
primary antibodies. All sections were coverslipped with
a mixture of 50% glycerin in 0.01 M PBS, and then
observed with a Leica fluorescence microscope, and
images were captured with a CCD spot camera.
Drugs
In vivo experiments: Ryanodine was initially dissolved in
dimethylsulfoxide (DMSO) and then diluted in physiolo-
gical saline to their final concentration immediately
before administration. The final DMSO concentration in
the diluted working solution was 0.25%. To evaluate the
effects of drugs on spinal LTP induction and mainte-
nance, drugs or vehicles were intrathecally injected over
a period of 2 min at a volume of 10 μlf o l l o w e db y5μl
0.9% sterile saline solution for flushing at 30 min before
or 60 min after tetanic stimuli. In vitro experiments:
Most of the drugs were purchased from sigma, including
bicuculline methiodide (10 μM), strychnine (1 μM), AP5
(50 μM), DNQX (10 μM), dantrolene (10 μM), 2-APB
(75 μM), cADPR (5 μM), L-NAME (50 μM). The other
drugs were TTX (0.5 μM), ryanodine (2 μM, 20 μM, 20
μM, Calbiochem) and caffeine (10 mM, Lancaster). All
drugs were prepared as stock solutions and diluted to
the required concentration (1:1000) with ACSF.
Statistics
Data were expressed as mean ± s.e.m. Effects of drugs
on LTP were compared with two-way repeated mea-
sures (RM) ANOVA (treatment and time) followed by
the Holm-Sidak tests. Pared t-test or t-test was used for
other electrophysiology experiments. P < 0.05 was con-
sidered statistically significant.
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